Mcdermott Health Podcast Channel

In the sixth episode of Season 2: Driving the Deal, Krist Werling, McDermott Partner and Co-Head of Private Equity and Brian Fortune, Senior Managing Director at Farragut Square Group, are joined by Brian Stimson, Healthcare Partner at McDermott Will and Emery and former Acting General Counsel & Principal Deputy General Counsel for US Department of Health and Human Services, discuss the unwinding of the COVID-19 Public Health Emergency (PHE). They discuss the following topics:  Expected end of the COVID-19 PHE Conclusion and future of telehealth flexibilities Medicaid eligibility issues associated with the end of the PHE Remaining PREP Act Declarations Next moves for CMS and other agencies

The key topics that should be receiving board attention in the near term have less to do with traditional operational matters, and more to do with social and economic issues of concern to the workforce and the mission. To bring understanding to these key concerns, we turn to our quarterly conversation with Ken Kaufman, Co-Founder and Managing Director of Kaufman Hall.   Ken has been visiting with clients and other leaders of the healthcare industry and has also been busy with his popular blog, addressing pressing subjects ranging from inflation to artificial intelligence. Ken has returned to our podcast today to share his insights on topics that include: Social justice board initiatives that have developed in the wake of the George Floyd murder. The impact of individual actions regarding equality at the CEO level. Addressing current workforce culture and employee retention concerns. The impact of rising inflation rates on hospitals and health systems. Realities and expectations of today’s board members.

In the fifth episode of Season 2: Driving the Deal, Brian Fortune, Senior Managing Director at Farragut Square Group, and guest co-host Holly Stokes, Senior Associate at Farragut Square Group, are joined by Justin Santa Cruz, Chief Development Officer at US Eye, an integrated, multi-specialty eye care platform. Recording live at McDermott’s annual Physician Practice Management & ASC Symposium in Nashville, Brian, Holly and Justin discussed: Operational and demand changes US Eye made in response to COVID-19 Current challenges and opportunities in the ophthalmology space Key features of ophthalmology assets for acquisitions and expansion The increasing role of private equity in ophthalmology The outlook for M&A activity in ophthalmology for 2022

The social and economic phenomenon known as “the Great Resignation” is now impacting hospital and healthcare CEOs. This, according to important new analysis from the well-known outplacement and search firm Challenger Gray & Christmas. To provide boards with a perspective on rising incidents of CEO resignation and their impact on healthcare organizations, we turn to our quarterly conversation with John Challenger and on the CEO employment status.   In this episode, host Michael Peregrine and John Challenger offer members of the board executive search, finance and HR committees an important update regarding CEO resignation trends, as well as an interpretation of economic data as it may impact health systems. Insights include:   Findings from the Challenger, Gray & Christmas report and their implications for the board’s search and succession process. Recommendations to boards regarding CEO monitoring and succession planning. How cultural changes and concerns are prompting the increase of CEO

In the fourth episode of Season 2: Driving the Deal, Brian Fortune, Senior Managing Director at Farragut Square Group, and guest co-host Jackie Williams, Head of Research at Farragut Square Group, are joined by Holly Stokes, Senior Associate at Farragut Square Group, live at McDermott’s annual Physician Practice Management & ASC Symposium in Nashville. Brian, Jackie and Holly discuss:  The stability and continued interest in gastroenterology and ophthalmology Specialties emerging as the next frontier for PPMs Challenges and special considerations for cardiology and ambulatory infusion The current macro pressures for PPMs including budget neutrality, clinical labor, sequester and pay-go

Part two of this series addresses key issues facing the board’s compensation committee when evaluating executive compensation, data analysis, recruitment and retention, and executive search matters.   This episode features industry leaders, Tim Cotter and Ralph DeJong, as they offer extraordinary insight on emerging priorities and trends impacting the compensation committees, including:   The evolution of annual and long-term incentive plans. The retention effect of executive pay and benefit programs. The continued relevance of for-profit compatibility data. Handling executive and director co-investment arrangements. Approaching CEO compensation earned from outside board service.

The board’s executive compensation committee has traditionally been one of the most prominent of all board functions, with its focus on such interconnected responsibilities as oversight of the executive compensation process, compensation data analysis, talent recruitment and executive search.   This episode is the first in a two-part discussion filled with valuable insight and the latest developments affecting compensation committees from two recognized health industry compensation and benefits experts, and . Tim and Ralph will discuss such important topics as:   The current state of salary, increase budgets, incentive award levels and emerging compensation practices. Developing retention and predictable transition strategies. Insights into application and interpretation of the IRS “rebuttable presumption” standards. Needed changes to highly prescriptive compensation philosophies. Tactics for encouraging executive retention beyond traditional cash incentives.

In the third episode of Season 2: Driving the Deal, Krist Werling, McDermott Partner and Co-Head of Private Equity, and Brian Fortune, Senior Managing Director at Farragut Square Group, are joined by Mark Francis, Head of Healthcare and Managing Director at Houlihan Lokey, live at McDermott’s annual Health Private Equity event in Miami. They discuss the following topics:  Healthcare sectors poised to see an increase in deal volume and activity Convergence of sectors creating new services in the next five years Future of orthopedic deals and changing sector activity “Transformative” deals and entering the innovative side of healthcare Value-based care and its impact on the market

In this second episode of Season 2 of Driving the Deal, Krist Werling, McDermott Partner and Co-Head of Private Equity, and Brian Fortune, Senior Managing Director at Farragut Square Group, are joined by Frank Martin, Head of Commercial Care at Farragut Square Group and a leader in commercial managed care. The topics discussed include: - The dominant trends in the commercial care market heading into 2022 - The state of beneficiary enrollment in Medicare Advantage - Managed care payor interaction in the Behavioral Health space and Medicaid - Proactive revisions to change of control specifications in deal contracts

COVID-19 concerns continue to dominate the boardroom agenda, from patient safety and access to care to understaffing and the concerns surrounding healthcare workers and management fatigue.   welcomes back , president of Orlikoff & Associates, Inc., for an update on where we stand two years into the COVID-19 pandemic, including:   Lessons that boards need to have learned two years into the pandemic. A realistic perspective on the transition from pandemic to endemic. The implications of operating a hospital or healthcare system at the forefront of COVID-19. Risks associated with government intervention in the healthcare standard of care crisis. Key issues facing board leadership at the beginning of 2022. Additional Resources:

In this episode of Driving the Deal, Krist Werling, McDermott Partner and Co-Head of Private Equity, and Brian Fortune, Senior Managing Director at Farragut Square Group, are joined by Holly Stokes, Senior Analyst at Farragut Square Group and veteran of numerous healthcare deals across the provider continuum. The topics they discuss include:  The state of the deal market in 2022  Deal questions surrounding PPMs  Overview changes impacting the post-acute and home health sectors Changing activity in the behavioral sectors with a focus on SUDS Increased deal activity in the digital health space 

As the most recent economic news indicates a slowdown in hiring coupled with a continuing decline in the unemployment rate and an increasingly tight job market, there seems to be a lot of confusion to clear up. Mix this all with a 7% unemployment rate and The Great Resignation, and we could all benefit from a little guidance. This week, welcomes back , for his perspective on economic trends and the messages he derives from them, what it means for board oversight and what he really thinks about The Great Resignation. John and Michael also discuss: Who are the people leaving their jobs in the Great Resignation and why are they leaving? How can recruiters target each group leaving during the Great Resignation? What is the ripple effect of offering promotions as an attraction for retention? What extent does the normalization of the pandemic affect the issues of retention and a tight labor market? Additional Resources:

As the US comes out of the dreaded fourth wave of the COVID-19 pandemic, the healthcare industry is facing one of the biggest unintended consequences of the pandemic — “tired of being your hero” syndrome. With healthcare professionals leaving the industry in the name of burnout, stress, safety, moral harm, and even personal freedom, a passive governance approach to caring for the caregivers simply won’t work anymore.    To review what board members need to do to be engaged in the face of these issues, as well as their governance implications, is joined by , President and CEO of leading healthcare strategic communications firm, Jarrard Phillips Cate & Hancock, and , Vice President and Co-Chief Legal Officer and Chief Officer team member for Health and Safety at Hackensack Meridian Health, one of the largest not-for-profit hospital systems in New Jersey. Together, they discuss how board leaders can address the growing crisis in the healthcare provider community, including:   Clearing up the

  As corporate directorship increases in complexity, the ability of directors to fully engage with the board agenda and to be an effective partner to management are two of the most critical corporate governance issues. In this environment, the ability of directors to be “certified” as to their competency to serve is attracting greater interest. To review what  board members need to know about director certification and how the National Association of Corporate Directors (NACD) works to support the profession of directorship, is joined by , COO, General Counsel, and Corporate Secretary for the NACD. She also leads NACD’s Director Certification Program and joins us to discuss the process and importance of engagement certification, including: ·         The driving focus behind and key elements of the NACD director qualification ·         How NACD works to support new directors and expand the pool of qualified director candidates ·      

In this unusual post-pandemic recovery period, the economic signals on which business leaders and policymakers rely to inform their decisions are going haywire. To help answer the difficult economic questions facing healthcare officers, executives and advisors, is joined by , CEO of Challenger, Gray & Christmas, a global outplacement firm, to discuss the board’s top post-pandemic economic challenges, including:   4 challenging economic factors impacting healthcare board members and trustees Insights into job participation rate and unemployment rates The current inflationary trend and its impact on healthcare organizations Focused work of key committees including finance, human capital, and strategic planning Trends in CEO turnover that search and succession committees need to watch   Additional Resources:  

Board responsibilities for COVD-19 related concerns aren’t over yet—not by a longshot. On this episode of the Governing Health podcast, and special guest , President of Orlikoff & Associates, Inc. and a national advisor on governance and leadership to the American Hospital Association, discuss:     COVID-19 focus while pursuing business resiliency Insights into the board’s role in preparing for potential new disease profiles Governance implications of mask-wearing and vaccination implementation Bracing for potential post-COVID-19 hospital readmissions The board’s public profile on public health matters Insights into the composition of the post-pandemic health system and hospital boards The most persistent long-term and acute implications of COVID-19 on society and healthcare systems Proactive steps that boards need to take when preparing for potential future surges and booster vaccinations     Additional Resources:

Driving the Deal Podcast: Restructuring and Bankruptcy Considerations 2020 brought a global liquidity crunch impacting many industries, including healthcare. In this episode of the Collaborative Transformation: Driving the Deal series, McDermott Partner Krist Werling speaks with colleague Felicia Perlman, Partner and Global Co-Head of McDermott’s Restructuring and Insolvency Practice Group. They discuss restructuring and bankruptcy trends, including the impacts to private equity and forecasts for the healthcare industry moving forward. Specific topics include: > Restructuring trends that are unique to the healthcare industry > Strategic guidance for private equity investors when preparing for a potential restructuring > Industries prime for restructuring and their impact on healthcare

In this episode of the Collaborative Transformation: Driving the Deal series, McDermott Partner Krist Werling is joined by Neil Krauter, National Practice Leader of Private Equity at Risk Strategies and Founder of Krauter & Company. With a wealth of experience in private equity insurance, Neil explains how private equity funds' needs have changed and addresses current trends in the space, including: > The evolving role of rep and warranty insurance in private equity investments > Insurance dynamics and issues in the rapidly changing SPAC deal space > Key insights into due diligence, billing and coding

In this episode of the Collaborative Transformation: Driving the Deal series, McDermott Partner Krist Werling speaks with Barry Freeman, Managing Director and Co-Head of Healthcare at Lincoln International, about current trends and topics surrounding the evolution of healthcare and its impact on private equity. They discuss: > A shifting mindset surrounding deals in the payor market > Key questions private equity investors want answered before investing in healthcare > Growth trends in government payor plans and their impact on providers > Investor insights into the home healthcare and telehealth spaces

In this episode of the Collaborative Transformation: Driving the Deal series, McDermott Partner Krist Werling is joined by Cheairs Porter and Geoff Smith, Managing Directors at Harris Williams, to discuss key topics surrounding mergers and valuations in the private equity space, including: > Key characteristics of various competitive fund managers and non-traditional private equity funds > Merging and scaling practice management assets and upcoming platform combination opportunities > Steps to running a successful auction process from a seller’s perspective > Valuation predictions for strong healthcare businesses in 2021